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Background
The spectrum of cancers seen in a hospital based Lynch
syndrome registry was examined to compare the inci-
dence of colorectal versus extracolonic cancers by sex,
race, mismatch repair (MMR) gene mutation, age at
diagnosis and index cancer. We also examined rare
extracolonic cancers that are not considered to be part
of Lynch syndrome.
Method
There were a total of 463 cancers recorded in 239
patients from 150 families enrolled in the Lynch syn-
drome registry at MD Anderson Cancer Center. Each of
these patients had a confirmed germline MMR
mutation. Overall there were 218 (47.1%) colorectal and
245 (52.9%) extracolonic cancers. There was no differ-
ence in the total number of colorectal and extracolonic
cancers in MLH1 mutation carriers (50.3% vs 49.7%)
whereas for MSH2 and MLH6 mutation carriers there
were more extracolonic than colorectal cancers overall
(54.2% vs. 45.8% for MSH2 and 61.9% vs. 38.1% for
MSH6). Men had fewer extracolonic cancers than color-
ectal (44.6% vs. 55.4%), whereas women had more extra-
colonic cancers than colorectal (58.9% vs. 41.1%). The
mean age at diagnosis for extracolonic cancers was
older than for colorectal, 48.6 vs. 44.5 years (P=<0.001).
There were no significant differences by race between
the colorectal and extracolonic cancers in Whites,
African Americans and Hispanics.
Results
The index cancer was colorectal in 54.8% of patients.
Among the extracolonic index cancers endometrial/uter-
ine was the most common (29.6%) followed by skin
(24.1%, of which 11.1% were confirmed cases of Muir-
Torre). Other index cancers were renal/ureter/bladder
(10.2%), upper GI/small intestine (6.5%), ovary (5.6%)
and hepatobiliary/pancreas (3.7%). It was interesting to
note that the index tumor was breast cancer in 5
patients (4.6%) although breast cancer is not considered
part of Lynch syndrome [1-3]. Other non-Lynch syn-
drome index cancers recorded were prostate (n=3,
2.8%), thyroid (n=2, 1.85%), cervix/vagina (n=2, 1.85%)
and 1 case each of thymoma, leukemia, lymphoma soft
palate, adenocarcinoma of the lung and fibroxanthoma
peritoneum. In addition, there was 1 index brain tumor
and 4 patients presented with metastatic disease (lung,
liver, unknown primary).
Conclusion
In this study, we found that Lynch syndrome patients
can commonly present with cancers other than colorec-
tal and endometrial. This has clinical relevance both for
diagnosis of Lynch syndrome and surveillance for can-
cers of different sites during followup of these patients.
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